The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma

BACKGROUND: The long-term survival in hepatocellullar carcinoma (HCC) patients after transarterial chemoembolization (TACE) remains dismal due to local and/or regional recurrence as well as distant metastasis. The efficacy of sorafenib in advanced HCC has been demonstrated and brought great hope. Re...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Xu-Dong, Chen, Cheng-Shi, Wang, Jian-Hua, Yan, Zhi-ping, Chen, Jie-min, Gong, Gao-quan, Liu, Qin-xin, Luo, Jian-jun, Liu, Lin-xiao, Liu, Rong, Qian, Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411397/
https://www.ncbi.nlm.nih.gov/pubmed/22721173
http://dx.doi.org/10.1186/1471-2407-12-263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411397/
https://www.ncbi.nlm.nih.gov/pubmed/22721173
http://dx.doi.org/10.1186/1471-2407-12-263

Ejemplares similares